Janux Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Gujrathi Sheila | — | Award / Grant | 2,500 | — | — | 110,528 | Jun 26, 2024 |
| Barrett Ronald W | — | Award / Grant | 2,500 | — | — | 2,500 | Jun 26, 2024 |
| Simson Jake | — | Award / Grant | 2,500 | — | — | 2,500 | Jun 26, 2024 |
| CAPPS VICKIE L | — | Award / Grant | 2,500 | — | — | 68,043 | Jun 26, 2024 |
| Lichter Jay | — | Sale | 691,525 | $54.75 | $37,860,994 | 3,340,018 | Jun 3, 2024 |
| Reardon Tighe | Acting Chief Financial Officer | Sale | 131,196 | $54.75 | $7,182,981 | 633,673 | Jun 3, 2024 |
| Avalon Ventures XI, L.P. | — | Sale | 677,279 | $54.75 | $37,081,025 | 3,271,216 | Jun 3, 2024 |
| Avalon Ventures XI, L.P. | — | Other | 447,949 | — | — | 4,031,543 | Feb 29, 2024 |
| Gujrathi Sheila | — | Other | 2,986 | — | — | 108,028 | Feb 29, 2024 |
| CAPPS VICKIE L | — | Other | 1,493 | — | — | 65,543 | Feb 29, 2024 |
| Reardon Tighe | Acting Chief Financial Officer | Purchase | 849,854 | $5.87 | $4,988,643 | 849,854 | Nov 13, 2023 |
| Lichter Jay | — | Purchase | 849,854 | $5.87 | $4,988,643 | 849,854 | Nov 13, 2023 |
| Avalon Ventures XI, L.P. | — | Purchase | 849,854 | $5.87 | $4,988,643 | 849,854 | Nov 13, 2023 |
| RA Capital Nexus Fund II, L.P. | — | Purchase | 495,008 | $12.46 | $6,167,800 | 8,117,246 | Jul 19, 2023 |
| Thompson Peter A. | — | Sale | 36,700 | $20.30 | $745,010 | 2,258,566 | Dec 29, 2021 |
| OrbiMed Genesis GP LLC | — | Sale | 3,700 | $20.30 | $75,110 | 231,098 | Dec 29, 2021 |
| Thompson Peter A. | — | Sale | 11,100 | $19.00 | $210,900 | 234,798 | Dec 21, 2021 |
| OrbiMed Genesis GP LLC | — | Sale | 11,100 | $19.00 | $210,900 | 234,798 | Dec 21, 2021 |
| OrbiMed Genesis GP LLC | — | Sale | 36,500 | $19.07 | $696,055 | 245,898 | Dec 16, 2021 |
| Thompson Peter A. | — | Sale | 356,800 | $19.07 | $6,804,176 | 2,403,566 | Dec 16, 2021 |
| Bregua Corp | — | Purchase | 58,823 | $17.00 | $999,991 | 3,749,250 | Jun 15, 2021 |
| Thompson Peter A. | — | Purchase | 117,650 | $17.00 | $2,000,050 | 282,398 | Jun 15, 2021 |
| ORBIMED ADVISORS LLC | — | Purchase | 588,203 | $17.00 | $9,999,451 | 2,760,366 | Jun 15, 2021 |
| Reardon Tighe | Acting Chief Financial Officer | C | 2,696,843 | — | — | 2,696,843 | Jun 15, 2021 |
| Lichter Jay | — | C | 1,138,665 | — | — | 1,330,815 | Jun 15, 2021 |
| Avalon Ventures XI, L.P. | — | C | 1,153,238 | — | — | 3,850,081 | Jun 15, 2021 |
| RA CAPITAL MANAGEMENT, L.P. | — | C | 1,719,238 | — | — | 1,719,238 | Jun 15, 2021 |